1 min read
Add as a preferred source on Google

Interpace Biosciences Posts $10.4 Million in Q3 Revenue, $0.26 GAAP Loss Per Share

Revenue increased 18.7% from the year-earlier quarter.

A graduated cylinder stands beside a precision balance in a laboratory / TokenPost.ai
A graduated cylinder stands beside a precision balance in a laboratory / TokenPost.ai

Interpace Biosciences generated $10.4 million in revenue for the third quarter, an 18.7% increase from the same period a year earlier.

The company recorded a GAAP loss of $0.26 per share for the quarter.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…